We 100% disagree with Barron's that General Electric's deal to sell its BioPharma business to Danaher (tkr: DHR), for $21.4 billion (original deal announced February 2019), should close soon. This is precisely the type of large deal struck at a peak market that will either get delayed indefinitely or negotiated down. Danaher has the upper … Continue reading GE’s BioPharma Deal Is at Risk
Some years ago many insurance carriers wrote tranches of long-term care (“LTC”) life insurance policies which have proved to be toxic. These “toxic” LTC policies - primarily written between 1999-2004 - were at the heart of a scathing critique of General Electric (tkr: GE) last week which ultimately accused the company of accounting fraud. While … Continue reading Toxic Long Term Care Policies: A Bane for Many. A Boon for Some.
I’m puzzled by the mess that is GE. The Company recently removed former CEO John Flannery after only 14 months at the helm only to replace him with a Board member (Larry Culp). I was a fan of Flannery’s effort to decentralize operations and to divest non-strategic businesses. However, I did not agree with all … Continue reading Boards: Perform Due Diligence on CEO Candidates Upfront. GE Is Still Cleaning Up Its Mess.Premium
GE CEO John Flannery has his work cut out starting with re-vamping GE's Board. Our advice? 100% of GE's BoD members should have experience within the industry verticals GE cares about. Equally important - GE BoD members should consist of a mix of Insiders and Outsiders with the weighting in favor of Insiders. More detail … Continue reading GE’s Board Is A Mess
Below is a post I wrote late last night and published to LinkedIn under CEORater. The post was in response to a Wall Street Journal article published about the use of an executive jet by former GE CEO Jeff Immelt which was not reported to the company's Board. Short story is that too much is … Continue reading GE & Air Immelt – Have A Fleet of Planes – So Long as You Are Outperforming